Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study

被引：0
|
作者：
Soraya Soulimane
Beverley Balkau
Yakima D. Vogtschmidt
Monika Toeller
John H. Fuller
Sabita S. Soedamah-Muthu
机构：
[1] Tilburg University,Center of Research on Psychological disorders and Somatic diseases (CoRPS), Department of Medical and Clinical Psychology
[2] Université Paris-Saclay,Clinical Epidemiology
[3] UVSQ,Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences
[4] Inserm,Institute for Food, Nutrition and Health
[5] CESP,Department of Epidemiology and Public Health
[6] University of Reading,undefined
[7] University of Reading,undefined
[8] Heinrich Heine University Düsseldorf,undefined
[9] University College London,undefined
来源：
Diabetologia | 2022年 / 65卷
关键词：
Cardiovascular health metrics; HbA; Risk factors; Type 1 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1169 / 1178
页数：9
相关论文
共 50 条
  • [1] Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study
    Soulimane, Soraya
    Balkau, Beverley
    Vogtschmidt, Yakima D.
    Toeller, Monika
    Fuller, John H.
    Soedamah-Muthu, Sabita S.
    DIABETOLOGIA, 2022, 65 (07) : 1169 - 1178
  • [2] Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes. The EURODIAB Prospective Complications study
    Soulimane, S.
    Vogtschmidt, Y. D.
    Toeller, M.
    Balkau, B.
    Chaturvedi, N.
    Fuller, J. H.
    Soedamah-Muthu, S. S.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S4 - S4
  • [3] Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes The EURODIAB Prospective Complications Study
    Gruden, Gabriella
    Barutta, Federica
    Chaturvedi, Nish
    Schalkwijk, Casper
    Stehouwer, Coen D.
    Witte, Daniel R.
    Fuller, John H.
    Perin, Paolo Cavallo
    Bruno, Graziella
    DIABETES CARE, 2012, 35 (07) : 1598 - 1604
  • [4] Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: the Eurodiab Prospective Complications Study
    Schram, MT
    Chaturvedi, N
    Fuller, JH
    Stehouwer, CDA
    JOURNAL OF HYPERTENSION, 2003, 21 (11) : 2035 - 2044
  • [5] Markers of inflammation are associated with microvascular complications and cardiovascular disease in Type 1 diabetes - the EURODIAB Prospective Complications study.
    Schram, MT
    Chaturvedi, N
    Schalkwijk, CG
    Fuller, JH
    Stehouwer, CDA
    DIABETOLOGIA, 2003, 46 : A43 - A43
  • [6] Incidence and risk factors of prolonged QTc interval in type 1 diabetes - The EURODIAB Prospective Complications Study
    Giunti, Sara
    Bruno, Graziella
    Lillaz, Emma
    Gruden, Gabriella
    Lolli, Valentina
    Chaturvedi, Nish
    Fuller, John H.
    Veglio, Massimo
    Cavallo-Perin, Paolo
    DIABETES CARE, 2007, 30 (08) : 2057 - 2063
  • [7] Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study
    J. W. J. Beulens
    J. S. Kruidhof
    D. E. Grobbee
    N. Chaturvedi
    J. H. Fuller
    S. S. Soedamah-Muthu
    Diabetologia, 2008, 51 : 1631 - 1638
  • [8] Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study
    Beulens, J. W. J.
    Kruidhof, J. S.
    Grobbee, D. E.
    Chaturvedi, N.
    Fuller, J. H.
    Soedamah-Muthu, S. S.
    DIABETOLOGIA, 2008, 51 (09) : 1631 - 1638
  • [9] Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study
    M. T. Schram
    N. Chaturvedi
    C. G. Schalkwijk
    J. H. Fuller
    C. D. A. Stehouwer
    Diabetologia, 2005, 48 : 370 - 378
  • [10] Risk factors for coronary heart disease in type 1 diabetic patients in Europe - The EURODIAB Prospective Complications Study
    Soedamah-Muthu, SS
    Chaturvedi, N
    Toeller, M
    Ferriss, B
    Reboldi, P
    Michel, G
    Manes, C
    Fuller, JH
    DIABETES CARE, 2004, 27 (02) : 530 - 537
12345